Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hart, G
9714  Ergebnisse:
Personensuche X
?
1

Striatal dopamine release tracks the relationship between a..:

Hart, G. ; Burton, T.J. ; Nolan, C.R..
Cell Reports.  43 (2024)  3 - p. 113828 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EPS4.03 ASOs reducing MUC5AC or MUC5B as a therapeutic appr..:

Ozeri Galai, E. ; Oren, Y.S. ; Stampfer, C.D....
Journal of Cystic Fibrosis.  23 (2024)  - p. S44 , 2024
Link: https://doi.org/10.1016/..
 
?
3

WS06.02 First-in-human clinical trial with SPL84, an ASO fo..:

Kerem, E. ; Caraco, Y. ; Wanounou, M....
Journal of Cystic Fibrosis.  23 (2024)  - p. S11 , 2024
Link: https://doi.org/10.1016/..
 
?
4

236 SPL84, an antisense oligonucleotide modulating the 3849..:

Barchad-Avitzur, O. ; Oren, Y. ; Stampfer, C....
Journal of Cystic Fibrosis.  22 (2023)  - p. S121 , 2023
Link: https://doi.org/10.1016/..
 
?
5

1365 PROACTIVE IT-ASSISTED CGA IN CARE HOMES IMPROVES ADHER..:

Attwood, D ; Vafidis, J ; Boorer, J...
Age and Ageing.  52 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

232 Nebulizer selection and characterization process with S..:

Cohen, A. ; Hart, G.
Journal of Cystic Fibrosis.  22 (2023)  - p. S119 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P015 Nebulizer selection and characterisation process with ..:

Cohen, A. ; Hart, G.
Journal of Cystic Fibrosis.  22 (2023)  - p. S68 , 2023
Link: https://doi.org/10.1016/..
 
?
8

116 First-in-human clinical trial with SPL84, an antisense ..:

Caraco, Y. ; Wanounou, M. ; Friedman, L....
Journal of Cystic Fibrosis.  22 (2023)  - p. S61 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P014 Safety and toxicity profile of SPL84, an inhaled antis..:

Hart, G. ; Barchad-Avitzur, O. ; Friedman, L....
Journal of Cystic Fibrosis.  22 (2023)  - p. S67-S68 , 2023
Link: https://doi.org/10.1016/..
 
?
10

231 Safety and toxicity profile of SPL84, an inhaled antise..:

Friedman, L. ; Barchad-Avitzur, O. ; Dahan, S....
Journal of Cystic Fibrosis.  22 (2023)  - p. S118 , 2023
Link: https://doi.org/10.1016/..
 
?
11

WS09.03 Delivery characterisation of SPL84 Inhaled Antisens..:

Ozeri-Galai, E. ; Friedman, L. ; Markovetz, M....
Journal of Cystic Fibrosis.  22 (2023)  - p. S18-S19 , 2023
Link: https://doi.org/10.1016/..
 
?
12

235 Reducing MUC5AC or MUC5B expression using antisense oli..:

Oren, Y. ; Stampfer, C. ; Elgrabli, R....
Journal of Cystic Fibrosis.  22 (2023)  - p. S120-S121 , 2023
Link: https://doi.org/10.1016/..
 
?
13

ePS6.07 SpliSense's ASO SPL84-23-1 properly distributes and..:

Hart, G. ; Galai, E. Ozeri ; Friedman, L....
Journal of Cystic Fibrosis.  21 (2022)  - p. S59-S60 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Evil Deeds in High Places: Christian America's Moral Strugg..:

Hart, D. G.
Church History.  91 (2022)  1 - p. 211-212 , 2022
Link: https://doi.org/10.1017/..
 
?
15

625 Manufacturing and device development for SPL84-23-1, an..:

Cohen, A. ; Hart, G.
Journal of Cystic Fibrosis.  21 (2022)  - p. S344-S345 , 2022
Link: https://doi.org/10.1016/..
 
1-15